Machida, Japan

Mayumi Shikano

This inventor holds 1 USPTO granted patent. Top assignees: Nippon Shoji Kaish Ltd., Sagami Chemical Research. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayumi Shikano. Retrieved from https://idiyas.com/inventor/mayumi-shikano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mayumi Shikano: Innovator in Aniline Derivatives

Introduction

Mayumi Shikano is a notable inventor based in Machida, Japan. She has made significant contributions to the field of chemistry, particularly in the development of aniline derivatives. Her work focuses on creating compounds that have potential applications in medical treatments.

Latest Patents

Shikano holds a patent for an aniline derivative that features a polyunsaturated fatty acid residue. This compound exhibits high inhibitory activity against ACAT derived from macrophages and shows promise as an agent for the prophylaxis and treatment of arteriosclerosis. The specific formula includes various alkyl and halogen components, showcasing her innovative approach to chemical synthesis.

Career Highlights

Throughout her career, Mayumi Shikano has worked with reputable companies such as Nippon Shoji Kaisha Ltd. and Sagami Chemical Research. Her experience in these organizations has allowed her to refine her skills and contribute to important research in her field.

Collaborations

Shikano has collaborated with esteemed colleagues, including Kazunaga Yazawa and Kazuo Watanabe. These partnerships have likely enhanced her research and development efforts, leading to her successful patent.

Conclusion

Mayumi Shikano's work in the field of aniline derivatives highlights her innovative spirit and dedication to advancing medical science. Her contributions are significant and continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…